{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:39:39Z","timestamp":1773898779182,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Intimal Sarcoma (IS) is an exceptionally rare and highly aggressive mesenchymal tumor with an uncertain origin. Its clinical and pathological characteristics are challenging to differentiate from other tumors based merely on histological and cytological morphology. Additionally, the immunohistochemical phenotype lacks specificity. Genomically, IS is distinguished by the amplification of the Mouse Double Minute 2 homolog (MDM2) gene. Presently, there are significant obstacles in clinical diagnosis and differential diagnosis of this condition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case demonstration<\/jats:title><jats:p>A 49-year-old male patient was hospitalized due to cough and dyspnea. An echocardiogram indicated a myxoma, leading to the performance of a partial cardiac tumor resection. Post-surgical pathological analysis revealed numerous spindle-shaped tumor cells organized in bundles. The cells displayed significant atypia, areas of necrosis, myxoid degeneration, and pathological mitotic figures. Immunophenotyping indicated positivity for Vimentin, Smooth Muscle Actin, and MDM2, focal positivity for ETS-Related Gene, and a Ki-67 index of 40%, with other markers being negative. Fluorescence <jats:italic>in situ<\/jats:italic> Hybridization genetic testing confirmed MDM2 gene amplification. The diagnosis was established as IS of the left atrium, World Health Organization grade 2. Post-surgery, six cycles of chemotherapy were administered. An 11-month follow-up period revealed tumor recurrence and progression, with multiple lesions but no distant metastases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A rare case of cardiovascular IS located in the left atrium has been documented. Diagnosing this condition poses significant challenges based solely on histological, cytomorphological, and immunophenotypic characteristics, as differentiation from angiosarcoma, malignant mesothelioma, synovial sarcoma, and myxofibrosarcoma is difficult. Consequently, diagnosing IS necessitates a comprehensive approach that integrates clinical presentation, echocardiography, and pathological examinations, encompassing morphology, immunohistochemistry, and genomic analysis. Surgical resection remains the primary treatment option. However, the rate of postoperative recurrence is high, and the prognosis remains poor. Adjuvant chemotherapy and radiotherapy are suggested. In advanced cases, comprehensive immunotherapy methods may be employed to enhance patient survival rates and quality of life.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1509505","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:10:33Z","timestamp":1739430633000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic trap: a case report of intimal sarcoma occurring in the left atrium"],"prefix":"10.3389","volume":"12","author":[{"given":"Hua","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/B978-0-323-44548-1.00094-2","article-title":"94-cardiac tumors","author":"Crispi","year":"2018","journal-title":"Obstetr Imaging Fetal Diagn Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.repc.2015.11.005","article-title":"Primary malignant cardiac tumors: surgical results","volume":"35","author":"Saraiva","year":"2016","journal-title":"Rev Port Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/heartjnl-2014-306364","article-title":"Cardiac masses and tumours","volume":"102","author":"Basso","year":"2016","journal-title":"Heart"},{"key":"B4","first-page":"300","volume-title":"WHO Classification of Tumours of the Lung, Pleura, thymus and Heart","author":"Travis","year":"2015"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1158\/0008-5472.CAN-10-1543","article-title":"Coactivated platelet-derived growth factor receptor \u03b1 and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma","volume":"70","author":"Dewaele","year":"2010","journal-title":"Cancer Res"},{"key":"B6","first-page":"315","article-title":"WHO Classification of Tumours Editorial Board","volume-title":"WHO Classification of Tumours of Soft Tissue and Bone","author":"Bode-Lesniewska","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.14740\/cr748w","article-title":"Functional mitral stenosis: imposture of primary cardiac intimal sarcoma","volume":"9","author":"Vinod","year":"2018","journal-title":"Cardiol Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.semdp.2007.10.006","article-title":"Primary malignant cardiac tumors","volume":"25","author":"Burke","year":"2008","journal-title":"Sem Diagn Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/ccr3.1089","article-title":"Primary cardiac intimal sarcoma masquerading as mitral stenosis","volume":"5","author":"Spartalis","year":"2017","journal-title":"Clin Caserep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/diagnostics10100776","article-title":"Clinical and imaging features of primary cardiac angiosarcoma","volume":"10","author":"Chen","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1089636","DOI":"10.3389\/fcvm.2023.1089636","article-title":"Case report: the diagnostic challenge of primary cardiac intimal sarcoma","volume":"10","author":"Ye","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/PAS.0000000000000184","article-title":"Intimal sarcoma in the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas","volume":"38","author":"Neuville","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.annpat.2019.08.001","article-title":"Cardiac intimal sarcoma: a case report of a rare tumor with peculiar histopathological findings","volume":"39","author":"Nassereddine","year":"2019","journal-title":"Ann Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/diagnostics11030496","article-title":"MDM2 Amplified sarcomas: a literature review","volume":"11","author":"Sciot","year":"2021","journal-title":"Diagnostics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41379-019-0293-x","article-title":"GLI1-amplifications Expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions","volume":"32","author":"Agaram","year":"2019","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1158\/0008-5472.CAN-17-0809","article-title":"MDM2 Is required for the survival and growth of p53-deficient cancer cells","volume":"77","author":"Feeley","year":"2017","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00428-017-2135-x","article-title":"Cardiac intimal sarcoma with PDGFRbeta mutation and co-amplification of PDGFRalpha and MDM2: an autopsy case analyzed by whole-exome sequencing","volume":"471","author":"Ito","year":"2017","journal-title":"Virchows Arch"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/cancers11091283","article-title":"Unique aberrations in intimal sarcoma identified by next-generation sequencing as potential therapy targets","volume":"11","author":"Roszik","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.3390\/ijms24087535","article-title":"Intimal sarcoma with MDM2\/CDK4 amplification and p16 overexpression: a review of histological features in primary tumor and Xenograft, with immunophenotype and molecular profiling","volume":"24","author":"Giner","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1055\/s-0039-1692409","article-title":"Prognostic factors for long-term survival after surgical resection of primary cardiac sarcoma","volume":"67","author":"Aboud","year":"2019","journal-title":"Thorac Cardiovasc Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.athoracsur.2010.01.078","article-title":"Long-term survival with heart transplantation for fibrosarcoma of the heart","volume":"90","author":"Coelho","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/cncr.23332","article-title":"Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients","volume":"112","author":"Karavasilis","year":"2008","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e009472","DOI":"10.1136\/jitc-2024-009472","article-title":"A multicenter, randomized, non-comparative, phase II study of nivolumab \u00b1 ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses","volume":"12","author":"Seligson","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jamaoncol.2020.3689","article-title":"Assessment of doxorubicin and pembrolizumab in patients with advanced anthra-cycline-naive sarcoma: a phase 1\/2 nonrandomized clinical trial","volume":"6","author":"Pollack","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1509505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:10:35Z","timestamp":1739430635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1509505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2025.1509505"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1509505","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"article-number":"1509505"}}